Association between suicidal behaviour and impaired glucose metabolism in depressive disorders

BMC Psychiatry

Volumn 15, Issue 1, 2015, Pages

  Koponen, Hannu ^a   Kautiainen, Hannu ^b,c   Leppänen, Esa ^d   Mäntyselkä, Pekka ^b,e   Vanhala, Mauno ^b,c,e  

^a UNIVERSITY OF HELSINKI   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c JYVÄSKYLÄ CENTRAL HOSPITAL   (Finland)

^d Public Utility Laboratory KESLAB Central Finland Hospital District   (Finland)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cholesterol; Depression; Glucose; Ideation; Insulin resistance; Suicidal behaviour; Suicidality; Suicide attempt; Triglyceride

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL; ANTIDEPRESSANT AGENT;

ALCOHOLISM; ARTICLE; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; DEPRESSION; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; TRIACYLGLYCEROL BLOOD LEVEL; ADULT; AGED; DEPRESSIVE DISORDER, MAJOR; EPIDEMIOLOGY; FINLAND; INSULIN RESISTANCE; METABOLIC SYNDROME X; MIDDLE AGED; PERSONALITY TEST; PHYSIOLOGY; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; SUICIDE ATTEMPT;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; EPIDEMIOLOGIC METHODS; FEMALE; FINLAND; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PERSONALITY INVENTORY; SUICIDAL IDEATION; SUICIDE, ATTEMPTED;

EID: 84937691411     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-015-0567-x     Document Type: Article

References (39)

1. Ayuso-Mateos JL, Vasquez-Barquero JL, Dowrick C, Lehtinen V, Dalgard OS, Casey P, et al. Depressive disorders in Europe: prevalence figures from the ODIN study. Br J Psychiatry. 2001;179:308-16.
2. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
3. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-105.
4. Isometsä E, Henriksson M, Marttunen M, Heikkinen M, Aro H, Kuoppasalmi K, et al. Mental disorders in young and middle aged men who commit suicide. BMJ. 1995;310:1366-7.
5. Bertolote JM, Fleischman A, De Leo D, Wasserman D. Suicide and mental disorders: do we know enough? Br J Psychiatry. 2003;183:382-3.
6. Van Reedt Dortland AKB, Vreeburg SA, Giltay EJ, Licht CMM, Vogelzangs N, van Veen T, et al. The impact of stress systems and lifestyle on dyslipidemia and obesity in anxiety and depression. Psychoneuroendocrinology. 2013;38:209-18.
7. Ceretta LB, Reus GZ, Abelaira HM, Jordana LK, Schwalm MT, Hoepers NJ, et al. Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients. Acta Diabetol. 2012;49 suppl 1:S227-34.
8. Han SJ, Kim HJ, Choi YJ, Lee KW, Kim DJ. Increased risk of suicidal ideation in Korean adults with both diabetes and depression. Diabetes Res Clin Pract. 2013;101:14-7.
9. Bot M, Pouwer F, de Jonge P, Tack JC, Geelhoed-Duijvestin PHLM, Snoek FJ. Differential associations between depressive symptoms and glycemic control in outpatients with diabetes. Diabet Med. 2013;30:e115-22.
10. Troisi A. Low cholesterol is a risk factor for attentional impulsivity in patients with mood symptoms. Psychiatry Res. 2011;188:83-7.
11. Stahl SM. Stahl's Essential Psychopharmacology. Neuroscientific Basis and Practical Applications. 3rd ed. Cambridge, UK: Cambridge University Press; 2008.
12. Muldoon MF, Mackey RH, Korytkowski MT, Flory JD, Pollock BG, Manuck SB. The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers. J Clin Endocrinol Metabolism. 2006;91:718-21.
13. Dunn AJ, Swiergiel AH, de Beaurepaire R. Cytokines as mediators of depression: What can we learn from animal studies? Neurosci Biobehav Rev. 2005;29:891-909.
14. Christmas DM, Potocar JP, Davies SJC. A biological pathway linking inflammation and depression: activation of indoleamine 2,3-dioxygenase. Neuropsychiatr Dis Treat. 2011;7:431-9.
15. Maes M. Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression. Progr Neuro-Psychopharmacol Biol Psychiatry. 2011;35:664-75.
16. Maes M, Ringel K, Kubera M, Berk M, Rybakowski J. Increased autoimmune activity against 5-HT: A key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression. J Affect Disord. 2012;136:386-92.
17. Banerjee M, Saxena M. Interleukin-1 (IL-1) family of cytokines: Role in Type 2 diabetes. Clinica Chimica Acta. 2012;413:1163-70.
18. Silic A, Karlovic D, Serretti A. Increased inflammation and lower platelet 5-HT in depression with metabolic syndrome. J Affect Disord. 2012;141:72-8.
19. Valkanova V, Ebmeier KP, Allan CL. CRP, IL-6 and depression: Asystematic review and meta-analysis of longitudinal studies. J Affect Disord. 2013;150:736-44.
20. Serafini G, Pompili M, Seretti ME, Stefani H, Palermo M, Coryell W, et al. The role of imflammatory cytokines in suicidal behavior: A systematic review. European Neuropsychopharmacol. 2013;23:1672-86.
21. Kan C, Silv N, Golden SH, Rajala U, Timonen M, Stahl D, et al. A systematic review and meta-analysis of the association between depression and insulin resistance. Diabetes Care. 2013;36:480-9.
22. Akbaraly TN, Kumari M, Head J, Ritchie K, Ancelin M-L, Tabak AG, et al. Glycemia, insulin resistance, insulin secretion, and risk of depressive symptoms in middle age. Diabetes Care. 2013;36:928-34.
23. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561-71.
24. Sheehan DV, Lecrubier Y. Mini-International Neuropsychiatric Interview (MINI). Tampa, FL: University of South Florida, Institute for Research in Psychiatry; 1994. Paris: INSERM-Hopital de la Salpetriere.
25. Katz A, Nambi SS, Mather K, Baron AD, Follman DA, Sullivan G, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrin Metab. 2000;85:2402-10.
26. Sokero PT, Melartin TK, Rytsälä HJ, Leskelä US, Lestelä-Mielonen PS, Isometsä ET. Suicidal ideation and attempts among psychiatric patients with major depressive disorder. J Clin Psychiatry. 2003;64:1094-100.
27. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, de Craen AJM, et al. Statins and the risk of incident diabetes: a collaborative meta-analysis of randomized statin trials. Lancet. 2010;375:735-42.
28. Mather AA, Cox BJ, Enns MW, Sareen J. Associations of obesity with psychiatric disorders and suicidal behaviors in a nationally representative sample. J Psychosom Res. 2009;66:277-85.
29. Kressel G, Trunz B, Bub A, Hülsman O, Wolters M, Lichtinghagen R, et al. Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Athetosclerosis. 2009;202:263-71.
30. Sublette ME, Galfalvy HC, Fuchs D, Lapidus M, Grunebaum MF, Oquendo MA, et al. Plasma kynurine levels are elevated in suicide attempters with major disorder. Brain Behav Immun. 2011;25:1272-8.
31. Suokas JT, Perälä J, Suominen K, Saari S, Lönnqvist J, Suvisaari JM. Epidemiology of suicide attempts among persons with psychotic disorder in the general population. Schizophrenia Res. 2010;124:22-8.
32. Mäntyselkä P, Korniloff K, Saaristo T, Koponen H, Eriksson J, Puolijoki H, et al. Association of depressive symptoms with impaired glucose regulation, screen-detected and previously known type 2 diabetes - findings from the Finnish D2D survey. Diabetes Care. 2011;34:71-6.
33. Stetler C, Miller GE. Depression and hypothalamic-pituitary-adrenal activation: A quantitative summary of four decades of research. Psychosomatic Med. 2011;73:114-26.
34. Belvedere Murri R, Pariante C, Mondelli V, Masotti M, Atti AR, Mellacqua Z, et al. HPA axis and aging in depression: Systematic review and meta-analysis. Psychoneuroendocrinology. 2014;41:46-62.
35. Malone KM, Waternaux C, Haas GL, Cooper TB, Li S, Mann JJ. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. Am J Psychiatry. 2003;160:773-9.
36. Olie E, Picot MC, Guillaume S, Abbar M, Courtet P. Measurement of total serum cholesterol in the evaluation of suicidal risk. J Affect Disord. 2011;133:234-8.
37. Tedders SH, Fokong KD, McKenzie LE, Wesley C, Yu L, Zhang J. Low cholesterol is associated with depression among US household population. J Affect Disord. 2011;135:115-21. 51: 1060-1063.
38. Tanskanen A, Vartiainen E, Tuomilehto J, Viinamäki H, Lehtonen J, Puska P. High serum cholesterol and risk of suicide. Am J Psychiatry. 2000;157:648-50.
39. Mather KJ, Hunt AE, Steinberg HO, Paradisi G, Hook G, Katz A, et al. Repeatability characteristics of simple indices of insulin resistance: Implications for research applications. J Clin Endocrinol Metabolism. 2001;86:5457-64.